![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » New Drug Submission for Abraxane Filed in Canada
New Drug Submission for Abraxane Filed in Canada
June 15, 2005
American Pharmaceutical Partners has filed a new drug Submission for Abraxane with the Therapeutic Products Directorate of Health Canada.
The submission seeks Health Canada's approval to market Abraxane in Canada for the treatment of metastatic breast cancer.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
21Oct